Acquisition speculation sent shares of Galectin Therapeutics Inc. (Nasdaq: GALT) soaring 68 cents to close at $2.60.
Speculators lift Galectin Therapeutics
September 21, 2016 at 18:30 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.